Upgrade to SI Premium - Free Trial

Aura Biosciences (AURA)

7.05 -0.15 (2.08%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Aura Biosciences, Inc. For: Jul 07 Filed by: Bender Jeremy July 8, 2026 4:12 PM - SEC Filing Form 3 Aura Biosciences, Inc. For: Jul 07 Filed by: Bender Jeremy July 8, 2026 4:10 PM - SEC Filing Form 8-K Aura Biosciences, Inc. For: Jul 03 July 8, 2026 7:18 AM - SEC Filing Aura Biosciences adds former Day One CEO to its board July 8, 2026 7:01 AM - StreetInsider Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors July 8, 2026 7:01 AM - Globe NewsWire Form 4 Aura Biosciences, Inc. For: Jul 01 Filed by: Kilroy Conor July 1, 2026 4:35 PM - SEC Filing Form DEF 14A Aura Biosciences, Inc. For: Aug 05 June 29, 2026 5:29 PM - SEC Filing Form PRE 14A Aura Biosciences, Inc. For: Aug 05 June 17, 2026 4:31 PM - SEC Filing Form 144 Aura Biosciences, Inc. Filed by: Gibney Anthony S June 16, 2026 4:31 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: Jun 16 Filed by: Gibney Anthony S June 16, 2026 4:30 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: Jun 11 Filed by: Bitetti Teresa Marie June 15, 2026 4:31 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: Jun 11 Filed by: Srivastava Sapna June 15, 2026 4:31 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: Jun 11 Filed by: Johnson David Michael June 15, 2026 4:31 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: Jun 11 Filed by: Mattessich Antony C. June 15, 2026 4:31 PM - SEC Filing Form 8-K Aura Biosciences, Inc. For: Jun 11 June 11, 2026 4:31 PM - SEC Filing Aura Biosciences completes enrollment in phase 3 choroidal melanoma trial June 1, 2026 8:00 AM - StreetInsider Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma June 1, 2026 8:00 AM - Globe NewsWire Form 4 Aura Biosciences, Inc. For: May 19 Filed by: Holles Natalie C. May 19, 2026 5:00 PM - SEC Filing Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 19, 2026 4:50 PM - Globe NewsWire Form S-8 Aura Biosciences, Inc. May 19, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G Aura Biosciences, Inc. Filed by: TCG Crossover GP II, LLC May 12, 2026 6:07 PM - SEC Filing Aura Biosciences to Participate in Upcoming Investor Conferences May 12, 2026 4:01 PM - Globe NewsWire Aura Biosciences, Inc. (AURA) Misses Q1 EPS by 6c May 11, 2026 5:10 PM - StreetInsider Form 10-Q Aura Biosciences, Inc. For: Mar 31 May 11, 2026 4:17 PM - SEC Filing Form 4 Aura Biosciences, Inc. For: May 07 Filed by: Matrix Capital Management Company, LP May 11, 2026 4:16 PM - SEC Filing Form SCHEDULE 13D/A Aura Biosciences, Inc. Filed by: Matrix Capital Management Company, LP May 11, 2026 4:15 PM - SEC Filing Form 8-K Aura Biosciences, Inc. For: May 11 May 11, 2026 4:07 PM - SEC Filing Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights May 11, 2026 4:01 PM - Globe NewsWire Form 3 Aura Biosciences, Inc. For: Apr 30 Filed by: Holles Natalie C. May 7, 2026 4:07 PM - SEC Filing Form 8-K Aura Biosciences, Inc. For: May 04 May 5, 2026 5:22 PM - SEC Filing Aura Biosciences closes $299 million public offering May 5, 2026 5:15 PM - StreetInsider Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares May 5, 2026 5:15 PM - Globe NewsWire Form 424B5 Aura Biosciences, Inc. May 5, 2026 6:03 AM - SEC Filing Form 8-K Aura Biosciences, Inc. For: Apr 30 May 4, 2026 4:20 PM - SEC Filing Aura Biosciences prices $260 million public offering at $6.00 per share May 4, 2026 9:03 AM - StreetInsider Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants May 4, 2026 9:03 AM - Globe NewsWire Form DEFA14A Aura Biosciences, Inc. May 4, 2026 8:06 AM - SEC Filing Form S-3MEF Aura Biosciences, Inc. May 4, 2026 7:31 AM - SEC Filing Form 424B5 Aura Biosciences, Inc. May 4, 2026 6:55 AM - SEC Filing Form 8-K Aura Biosciences, Inc. For: Apr 29 May 4, 2026 6:18 AM - SEC Filing Aura Biosciences announces public offering of common stock and warrants May 4, 2026 6:03 AM - StreetInsider Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants May 4, 2026 6:03 AM - Globe NewsWire Aura Biosciences names Natalie Holles CEO as phase 3 trial nears completion May 4, 2026 6:01 AM - StreetInsider Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion May 4, 2026 6:01 AM - Globe NewsWire Aura Biosciences (AURA) PT Raised to $24 at H.C. Wainwright April 29, 2026 6:11 AM - StreetInsider Full Article List